Cargando…

Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas

Sinonasal papillomas are characterized by their potential for frequent recurrences and malignant progression. Currently, the role of human papillomavirus (HPV) infection in sinonasal papillomas is unclear. A study was conducted to elucidate the impact of HPV infection on recurrence and malignant pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Paehler vor der Holte, Anja, Fangk, Inger, Glombitza, Sabine, Wilkens, Ludwig, Welkoborsky, Hans J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877357/
https://www.ncbi.nlm.nih.gov/pubmed/33350606
http://dx.doi.org/10.1002/cam4.3642
_version_ 1783650150653100032
author Paehler vor der Holte, Anja
Fangk, Inger
Glombitza, Sabine
Wilkens, Ludwig
Welkoborsky, Hans J.
author_facet Paehler vor der Holte, Anja
Fangk, Inger
Glombitza, Sabine
Wilkens, Ludwig
Welkoborsky, Hans J.
author_sort Paehler vor der Holte, Anja
collection PubMed
description Sinonasal papillomas are characterized by their potential for frequent recurrences and malignant progression. Currently, the role of human papillomavirus (HPV) infection in sinonasal papillomas is unclear. A study was conducted to elucidate the impact of HPV infection on recurrence and malignant progression of sinonasal papillomas. One hundred and seven patients with 151 tumors could be examined. One hundred and one patients suffered from benign papilloma, mostly inverted papillomas (IP); six patients suffered from carcinomas in situ and squamous cell carcinomas (SCC) ex‐IP. Recurrent IP were more often HPV‐positive than non‐recurrent tumors (38.8% vs. 60%–65%). Low‐risk (LR) HPV infection (especially HPV 6) increased the risk of tumor recurrences (p = 0.0385 and p = 0.0556, respectively). IP and oncocytic papillomas (both lesions are known for their malignant potential) were more often high‐risk (HR) HPV‐positive (15.5% and 16.7%) than fungiform papilloma (which usually does not progress to carcinoma). CIS and SCC ex‐IP displayed higher HPV rates than benign IP (83.3% vs. 38.8%), especially higher rates of HR‐HPV (66.7% vs. 23.8%, p = 0.0415). Data from this study endorse the hypothesis that recurrence of sinonasal papillomas is promoted by LR‐HPV infection and that malignant progression of IP is promoted by HR‐HPV infection.
format Online
Article
Text
id pubmed-7877357
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78773572021-02-18 Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas Paehler vor der Holte, Anja Fangk, Inger Glombitza, Sabine Wilkens, Ludwig Welkoborsky, Hans J. Cancer Med Clinical Cancer Research Sinonasal papillomas are characterized by their potential for frequent recurrences and malignant progression. Currently, the role of human papillomavirus (HPV) infection in sinonasal papillomas is unclear. A study was conducted to elucidate the impact of HPV infection on recurrence and malignant progression of sinonasal papillomas. One hundred and seven patients with 151 tumors could be examined. One hundred and one patients suffered from benign papilloma, mostly inverted papillomas (IP); six patients suffered from carcinomas in situ and squamous cell carcinomas (SCC) ex‐IP. Recurrent IP were more often HPV‐positive than non‐recurrent tumors (38.8% vs. 60%–65%). Low‐risk (LR) HPV infection (especially HPV 6) increased the risk of tumor recurrences (p = 0.0385 and p = 0.0556, respectively). IP and oncocytic papillomas (both lesions are known for their malignant potential) were more often high‐risk (HR) HPV‐positive (15.5% and 16.7%) than fungiform papilloma (which usually does not progress to carcinoma). CIS and SCC ex‐IP displayed higher HPV rates than benign IP (83.3% vs. 38.8%), especially higher rates of HR‐HPV (66.7% vs. 23.8%, p = 0.0415). Data from this study endorse the hypothesis that recurrence of sinonasal papillomas is promoted by LR‐HPV infection and that malignant progression of IP is promoted by HR‐HPV infection. John Wiley and Sons Inc. 2020-12-22 /pmc/articles/PMC7877357/ /pubmed/33350606 http://dx.doi.org/10.1002/cam4.3642 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Paehler vor der Holte, Anja
Fangk, Inger
Glombitza, Sabine
Wilkens, Ludwig
Welkoborsky, Hans J.
Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas
title Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas
title_full Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas
title_fullStr Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas
title_full_unstemmed Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas
title_short Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas
title_sort impact of human papillomaviruses (hpv) on recurrence rate and malignant progression of sinonasal papillomas
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877357/
https://www.ncbi.nlm.nih.gov/pubmed/33350606
http://dx.doi.org/10.1002/cam4.3642
work_keys_str_mv AT paehlervorderholteanja impactofhumanpapillomaviruseshpvonrecurrencerateandmalignantprogressionofsinonasalpapillomas
AT fangkinger impactofhumanpapillomaviruseshpvonrecurrencerateandmalignantprogressionofsinonasalpapillomas
AT glombitzasabine impactofhumanpapillomaviruseshpvonrecurrencerateandmalignantprogressionofsinonasalpapillomas
AT wilkensludwig impactofhumanpapillomaviruseshpvonrecurrencerateandmalignantprogressionofsinonasalpapillomas
AT welkoborskyhansj impactofhumanpapillomaviruseshpvonrecurrencerateandmalignantprogressionofsinonasalpapillomas